文献速递病毒性肝炎

婴儿期接种疫苗青少年加强后对乙肝表面抗原变异株的免疫应答

Diverse immune responses to HBV surface epitope variants after vaccine booster in adolescents immunized in infancy.
PubMed 文献 · Clin Microbiol Infect · 2019-02-13

研究纳入142名15-21岁、婴儿期完成乙肝疫苗接种但抗-HBs阴性的青少年,评估加强针前后对HBsAg及T细胞表位变异株的细胞免疫和抗体亲和力。单剂加强后8.6%仍抗-HBs阴性,<17岁者抗-HBs滴度更高;细胞免疫对部分变异株改善,但对sG145R的抗体亲和力及部分表位IFN-γ应答仍受损。

要点

  • 约10%抗-HBs消失的青少年也失去免疫记忆,单剂加强后8.6%仍阴性。
  • 加强前HBsAg特异性细胞增殖存在于90.6%受试者,加强后T细胞表位应答增强。
  • 加强后对sG145R抗体亲和力及部分表位IFN-γ应答仍低于野生型。

核心结论

  • 在婴儿期接种后抗-HBs消失的青少年中,约10%也失去免疫记忆,加强针可改善对部分T细胞表位变异株的细胞免疫,但对sG145R的抗体亲和力及某些表位的IFN-γ应答仍受损。

研究设计与样本

  • 招募142名15至21岁、婴儿期完成乙肝疫苗全程接种但抗-HBs阴性的青少年,评估加强针前后对HBsAg及T细胞表位变异株的细胞免疫,加强后评估抗体亲和力。

主要发现

  • 单剂加强后140名中12名(8.6%)仍抗-HBs阴性。
  • 抗-HBs滴度在<17岁者更高(几何均值337.9 ± 10.9 vs. 157.4 ± 16.6 mIU/mL,p=0.012)。
  • 加强前HBsAg特异性细胞增殖存在于58/64(90.6%)受试者。
  • T细胞表位增殖应答率加强前后分别为37.8%和72.6%(p<0.001),刺激指数从1.25 ± 1.70升至2.53 ± 2.32(p<0.001)。
  • HBsAg特异性IL-5和IFN-γ分泌T细胞增强(分别从45 ± 10和50 ± 4升至420 ± 328和355 ± 424 spot-forming cells/10^6 cells,p<0.001)。

关键数值与推荐

  • 加强后对含R24K的表位16-33的IFN-γ分泌T细胞及对sG145R的抗体亲和力仍显著低于野生型。

临床怎么用

  • 对婴儿期接种后抗-HBs消失的青少年,加强针可增强对部分变异株的细胞免疫,但需关注对sG145R等变异株的免疫应答仍不充分。

局限性

  • 样本量有限,未报告长期随访及临床保护力数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to investigate immunity against hepatitis B surface antigen (HBsAg) mutants before and after boosters in adolescents who had lost antibodies against HBsAg (anti-HBs) despite neonatal vaccination. METHODS: We recruited 142 participants from 15 to 21 years old who had received complete vaccination in infancy but became anti-HBs-negative. Cellular immunity to HBsAg and T-cell epitope variants was assessed before and after boosters. Antibody affinity to variants was assessed after boosters. RESULTS: After one dose of booster, 12 out of 140 (8.6%) participants remained anti-HBs-negative. Anti-HBs titres were higher in those participants <17 (geometric mean, 337.9 ± 10.9 vs. 157.4 ± 16.6 mIU/mL, p = 0.012). Before the booster, HBsAg-specific cell proliferation was present in 58 out of 64 (90.6%) participants. The proliferation response rates to T-cell epitopes were 37.8% and 72.6% (p < 0.001) before and after the booster, respectively. The stimulation index improved from 1.25 ± 1.70 to 2.53 ± 2.32 (p < 0.001) for various T-cell epitopes. HBsAg-specific interleukin (IL)-5- and interferon (IFN)-γ-secreting T-cells were enhanced (45 ± 10 and 50 ± 4 to 420 ± 328 and 355 ± 424 spot-forming cells/106 cells, respectively, p < 0.001). IFN-γ-secreting T cells to epitope 16-33 containing R24K and the antibody affinity to sG145R were still significantly lower than to the wild type. CONCLUSIONS: In immunized adolescents who lost anti-HBs, around 10% also lost immune memory. Cellular immunity to some T-cell epitope variants improved after the booster. Antibody affinity to sG145R and the IFN-γ-secreting cell response to some epitope 16-33 variants were still impaired even after booster administration.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Lai MW, Liang KH, Yeh CT, et al. Diverse immune responses to HBV surface epitope variants after vaccine booster in adolescents immunized in infancy. Clin Microbiol Infect. 2019. PMID: 30771531. doi:10.1016/j.cmi.2019.02.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。